#Vascular Stents Market

[jameswilliam4u]

Global Vascular Stents Market Share, Trends & Forecast | 2024 - 2032

The global vascular stents market is a critical segment of the healthcare industry, especially within the realm of cardiovascular treatments. As of 2023, the market size reached a value of almost USD 10.57 billion and is projected to grow at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2032, reaching an estimated USD 17.10 billion by the end of the forecast period. This robust growth trajectory reflects the increasing demand for vascular stents, which are primarily used in the treatment of atherosclerosis, coronary artery disease, and peripheral artery disease (PAD).

[soumyafwr]

Vascular Stent Market Size, Overview, Share and Forecast 2031

[alicesara611]

A Deep Dive into the Non Vascular Stent Market: Key Players and Strategies By 2022 to 2028

The global non-vascular stents market is expected to grow from US$ 970.6 million in 2022 to US$ 1,326.3 million by 2028, at a CAGR of 5.5%. Non-vascular stents are medical devices used to treat blockages or narrowed passages in various parts of the body, such as the gastrointestinal tract, respiratory tract, and urinary tract. They are made of various materials, such as metal, plastic, and silicone, and are available in a variety of shapes and sizes.

Non-vascular stents are medical devices that are used to treat a variety of non-vascular conditions. They are typically made of metal or plastic and are inserted into the body through a minimally invasive procedure. Non-vascular stents can be used to open up blocked passageways, support weakened structures, or deliver drugs to specific areas of the body.

Get Your Report Sample to Gain Comprehensive Insights! https://bit.ly/3MKbIgD

Market Drivers:

The growth of the non-vascular stents market is being driven by a number of factors, including:

The increasing prevalence of chronic diseases such as cancer, heart disease, and diabetes, which can lead to blockages in various parts of the body.

The rising demand for minimally invasive procedures to treat these diseases.

The technological advancements in non-vascular stents, such as the development of drug-eluting stents and biodegradable stents.

The increasing awareness of non-vascular stents among patients and physicians.

Key Takeaways:

The global non-vascular stents market is expected to grow from US$ 970.6 million in 2022 to US$ 1,326.3 million by 2028, at a CAGR of 5.5%.

The growth of the market is attributed to factors such as the increasing prevalence of chronic diseases, the rising demand for minimally invasive procedures, and the growing awareness of non-vascular stents.

The esophageal stent segment is expected to account for the largest share of the market during the forecast period. This is due to the high prevalence of esophageal cancer and the increasing use of esophageal stents for the treatment of this condition.

The North American region is expected to dominate the market during the forecast period. This is due to the high prevalence of chronic diseases and the well-established healthcare system in the region.

Regional Analysis:

North America is the largest market for non-vascular stents, followed by Europe and Asia Pacific. The growth of the North American market is being driven by the high prevalence of chronic diseases and the rising demand for minimally invasive procedures. The growth of the European market is being driven by the increasing awareness of non-vascular stents and the technological advancements in this field. The growth of the Asia Pacific market is being driven by the rising disposable incomes and the increasing demand for healthcare services.

Key Players:

Boston Scientific

COOK MEDICAL

ELLA - CS, s.r.o.

OLYMPUS

B. BRAUN

MEDtronic

Merit Medical Systems, Inc.

H.C.W. Inc.

Biotronik AG

Taewoong Medical Co., Ltd.

ABIOMED, Inc.

Segmentation:

By Product Type:

Esophageal Stents

Biliary Stents

Ureteric Stents

Duodenal Stents

Tracheal Stents

Others

By Application:

Benign Diseases

Malignant Diseases

Others

By Region:

North America

Europe

Asia Pacific

Latin America

Middle East and Africa

[mysticalfungalaxy]

Non-Vascular Stents Market is expected to be valued at US$ 1.9 billion by 2032 | FMI

The Non-Vascular Stents Market is expected to grow at a CAGR of 4.5% over the anticipated timeframe. (2022 – 2032). In 2022, it is projected that the industry will be worth US$ 1.21 billion, and by 2032, it will be worth US$ 1.9 billion.

The global non-vascular stents market is expected to move forward in response to the growing demand for minimally-invasive procedures. Rising technological and material advancements are assisting in the development of specially designed stents for use in a variety of indications thereby fueling the overall non-vascular stents market growth.

To learn more about this report @ https://www.futuremarketinsights.com/reports/non-vascular-stents-market

Non-vascular stents use small, precise incisions, resulting in scars that are smaller and less visible than those left by traditional surgical techniques, putting the patient’s safety in jeopardy. Such surgery is associated with a faster recovery period, resulting in a shorter hospital stay for the patient, encouraging many to opt for the same.

Furthermore, patients are less likely to contract hospital-acquired illnesses like bloodstream infections and urinary tract infections if they stay in the hospital for a shorter period of time, in turn, propelling the demand for non-vascular stents.

The most visible and prominent factor spiking the sales of non-vascular stents is a surge in cases of chronic obstructive pulmonary disease (COPD), which is caused by smoking, lung cancer, tracheobronchial malacia, and chemical exposure.

Numerous innovations are taking place in the non-vascular stents market as new medical devices are developed to track gastrointestinal tract, urinary tract, and airway tract.

Non-vascular stents market trends are fostered by rising healthcare spending in developing countries, government and private insurance companies’ helpful medical reimbursement policies, and the proliferation of hospitals and ambulatory surgical centers.

The non-vascular stents market is segmented by product type and by region, where by product type, the market is divided into gastrointestinal stents, pulmonary stents, urological stents, and others.

Non-vascular implants are medical devices designed to keep open and support non-vascular structures within the body. Unlike vascular stents, which are used to treat blockages in blood vessels, non-vascular stents are used to treat a variety of conditions in other parts of the body.

Key Takeaways:

Based on product type, the urological stents segment is likely to dominate the non-vascular stents market with a CAGR of 4.3% through 2032.

The US non-vascular stents market is expected to capture a sizeable non-vascular stents market share accounting for around US$659.1 million by 2032.

By 2032, the UK non-vascular stents market is expected to be valued at US$ 80.6 million, growing at a CAGR of 3.3%.

With a CAGR of 3.6% during the forecast period, China non-vascular stents market size is predicted to be apprised at US$ 128.1 million by 2032.

The Japan non-vascular stents market, with a CAGR of 3.9%, is projected to garner a worth of US$ 109.8 million by 2032.

Key Players:

Medtronic plc.

Glaukos Corporation

Boston Scientific Corporation

ELLA – CS, s.r.o.

CONMED Corporation

Key Segments

By Product:

Gastrointestinal Stents

Biliary

Duodenal

Colonic

Pancreatic

Oesophageal Stents

Pulmonary Stents

Silicone Airway

Metallic Airway

Urological Stents

Others

[stickyleadybloger]

https://dailybusinesspost.com/global-vascular-stents-market-size-growing-tremendously-asserts-mrfr-unleashing-industry-forecast-up-to-2030/

Global Vascular Stents Market Size Growing Tremendously; Asserts MRFR Unleashing Industry Forecast Up To 2030

[willyskristina]

Embolic Protection Devices Market

Embolic Protection Devices Market Size, Share, Trends: Medtronic plc Leads

Rising Adoption of TAVR Procedures Drives Demand for Embolic Protection

Market Overview:

The Embolic Protection Devices Market is projected to grow at a CAGR of 8.2% from 2024 to 2031. North America currently dominates the market, with the highest market share and revenue. Key metrics include the increasing prevalence of cardiovascular diseases, growing adoption of minimally invasive procedures, and technological advancements in embolic protection devices. The market is experiencing significant growth due to the rising incidence of cardiovascular and neurovascular diseases globally. Embolic protection devices play a crucial role in preventing complications during endovascular procedures, driving their adoption in healthcare settings. The increasing geriatric population and the growing demand for effective treatment options for vascular diseases are also contributing to market expansion.

DOWNLOAD FREE SAMPLE

Market Trends:

A significant trend driving the embolic protection devices market is the rising adoption of transcatheter aortic valve replacement (TAVR) procedures. TAVR has emerged as a minimally invasive alternative to traditional open-heart surgery for treating severe aortic stenosis, particularly in high-risk patients. As TAVR procedures gain popularity, the demand for embolic protection devices has surged to mitigate the risk of periprocedural stroke and other embolic complications. The growing acceptance of TAVR among patients and healthcare providers, supported by expanding indications for its use in lower-risk patients, has led to substantial increases in procedure volumes worldwide.

Market Segmentation:

Distal filter devices currently hold the largest market share in the embolic protection devices segment. These devices are widely preferred due to their ability to capture and remove embolic debris while maintaining blood flow during endovascular procedures. Their versatility across various applications, including carotid artery stenting, saphenous vein graft interventions, and TAVR, contributes to their dominance. Recent advancements in distal filter technology, such as improved capture efficiency and lower crossing profiles, have enhanced their performance and ease of use. Industry leaders such as Boston Scientific Corporation and Medtronic plc have reported significant growth in their embolic protection portfolios, driven by the strong performance of their distal filter devices.

Market Key Players:

The embolic protection devices market is highly competitive, with major players focusing on technological innovation and strategic alliances. Key companies such as Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Cardinal Health, Inc., Silk Road Medical, Inc., and W. L. Gore & Associates, Inc. are at the forefront, driving innovation and setting trends in the market. These firms invest heavily in R&D to introduce advanced embolic protection devices tailored to the needs of healthcare providers.

Contact Us:

Name: Hari Krishna

Email us: hari.krishna@aurorawaveintellects.com

Website: https://aurorawaveintellects.com/

[kristinahertzz]

Bare Metal Stents Market

Bare Metal Stents Market Size, Share, Trends: Medtronic plc Leads

Increasing Focus on Thin-Strut Bare Metal Stents Drives Market Forward

Market Overview: 

The Bare Metal Stents Market is projected to grow significantly from 2024 to 2031. North America currently dominates the market, accounting for the largest share of global revenue. Key metrics include the number of coronary and peripheral artery disease cases, stent implantation procedures, and regulatory approvals for new stent designs. The rising prevalence of cardiovascular diseases, technological advancements in stent design, and the cost-effectiveness of bare metal stents in certain patient groups are all contributing to the market's continued growth. However, the business is facing difficulties from the increasing use of drug-eluting stents and bioresorbable vascular scaffolds.

DOWNLOAD FREE SAMPLE

Market Trends: 

The development and use of thin-strut bare metal stents is a major market trend. These innovative designs are intended to reduce the risk of restenosis while enhancing overall patient outcomes. Thin-strut stents provide more flexibility, deliverability, and the potential for lower rates of in-stent restenosis than thicker stents. Recent study has shown that thin-strut bare metal stents can have similar safety and efficacy profiles to some first-generation drug-eluting stents, particularly in patients with a high risk of bleeding disorders.

Market Segmentation: 

The Coronary Artery Disease category presently commands the largest market share in the Bare Metal Stents business. This dominance stems primarily from the high global prevalence of coronary artery disease and the lengthy history of percutaneous coronary intervention (PCI) as a standard treatment option. While drug-eluting stents are the preferred option for many patients, bare metal stents nevertheless play an important role in several therapeutic situations. Recent advances in bare metal stent design, such as the development of cobalt-chromium alloys, have allowed for the production of thinner strut stents, potentially minimising the risk of restenosis while maintaining the mechanical strength required for vascular support.

Market Key Players: 

Prominent players in the Bare Metal Stents Market include Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Biosensors International Group, Ltd., Terumo Corporation, B. Braun Melsungen AG, Biotronik SE & Co. KG, Stentys SA, Hexacath, and MicroPort Scientific Corporation. These companies are at the forefront of the industry, continuously innovating and expanding their product portfolios to meet the evolving market demands. Their strategic initiatives and robust distribution networks have enabled them to maintain a strong market presence and drive growth.

Contact Us:

Name: Hari Krishna

Email us: hari.krishna@aurorawaveintellects.com

Website: https://aurorawaveintellects.com/

[stephengrand]

North America Balloon Catheters Market Size, Share, Trends, Growth, Analysis, Forecast | 2024-2032

The North America balloon catheters market is poised for significant growth in the coming years, with the market size valued at USD 1.3 billion in 2023. It is expected to expand at a robust compound annual growth rate (CAGR) of 10.59% during the forecast period of 2024-2032, reaching an estimated value of USD 3.3 billion by 2032. This growth is largely driven by the increasing prevalence of cardiovascular diseases, the adoption of minimally invasive surgical procedures, and technological advancements in balloon catheter design.

Balloon catheters are medical devices that play a vital role in treating a range of cardiovascular conditions, such as coronary artery disease (CAD), peripheral artery disease (PAD), and other vascular disorders. The balloon catheter is inserted into a blood vessel, where it is inflated to widen narrowed or blocked arteries, thereby improving blood flow. This procedure, known as angioplasty, is commonly used to prevent heart attacks and strokes.

Get a Free Sample Report with Table of Contents : https://www.expertmarketresearch.com/reports/north-america-balloon-catheters-market/requestsample

This article delves into the key drivers, trends, challenges, market segmentation, and competitive landscape of the North American balloon catheters market. Additionally, it explores frequently asked questions (FAQs) about balloon catheters and highlights the key players shaping the market.

Market Drivers: Why Is the North America Balloon Catheters Market Expanding?

Several factors contribute to the expected growth of the balloon catheters market in North America:

1. Increasing Prevalence of Cardiovascular Diseases

The rise in cardiovascular diseases, including coronary artery disease, peripheral artery disease, and stroke, has been a major factor driving the demand for balloon catheter procedures. According to the American Heart Association, nearly 48% of the adult population in the U.S. has some form of cardiovascular disease. The growing number of patients requiring angioplasty or stenting has significantly boosted the adoption of balloon catheters.

2. Technological Advancements in Balloon Catheter Design

Innovation in balloon catheter design has improved their performance, safety, and ease of use, which has contributed to their increased adoption. Newer catheters are designed to have higher durability, smaller profiles, and better maneuverability, enabling surgeons to perform more complex procedures with greater precision. These advancements are expected to further fuel the growth of the market.

3. Shift Towards Minimally Invasive Procedures

Minimally invasive surgeries, including angioplasty, have become the preferred treatment option for many cardiovascular conditions due to their shorter recovery times, reduced risk of complications, and lower overall healthcare costs. Balloon catheter-based angioplasty procedures are less invasive than traditional surgery, which has increased their adoption across North America.

4. Aging Population

The ageing population in North America is another significant factor contributing to the growth of the balloon catheters market. As people age, the incidence of cardiovascular diseases increases, leading to a greater demand for interventional procedures like angioplasty, which often require balloon catheters.

5. Rising Healthcare Expenditure

Increased healthcare spending in North America, particularly in the U.S., has led to the adoption of advanced medical devices and treatments. The growing demand for high-quality healthcare services, along with the introduction of reimbursed medical procedures, is driving the use of balloon catheters for a range of cardiovascular treatments.

Market Challenges: Factors Limiting Growth

Despite the promising growth of the balloon catheters market, there are several challenges that could hinder its expansion:

1. High Cost of Balloon Catheters

One of the primary challenges facing the balloon catheter market is the high cost of advanced devices. While the technology behind balloon catheters continues to improve, the cost of these devices can be prohibitively high, especially for patients without insurance coverage or in regions with limited healthcare resources.

2. Risk of Complications During Procedure

While balloon catheter procedures are generally considered safe, there is still a risk of complications, such as arterial dissection, perforation, or restenosis (narrowing of the artery again after treatment). The occurrence of these complications can result in longer recovery times, additional treatments, or even the need for open surgery, which may deter some patients from opting for balloon angioplasty.

3. Regulatory Hurdles

The regulatory approval process for medical devices can be lengthy and costly. Manufacturers of balloon catheters must meet strict standards set by regulatory bodies, such as the U.S. Food and Drug Administration (FDA), which can delay the introduction of new products to the market.

Market Segmentation

The North American balloon catheters market can be segmented based on the following parameters:

1. Type of Balloon Catheters

Angioplasty Balloon Catheters: Used for coronary and peripheral artery procedures to widen narrowed or blocked arteries.

Cutting Balloon Catheters: These balloons have small blades that make incisions in the artery during inflation, enabling more effective dilation.

Scoring Balloon Catheters: These balloons have a scored surface that allows for better dilation of the arteries, particularly in cases of severe stenosis.

Drug-Eluting Balloon Catheters: These balloons are coated with drugs that help prevent restenosis after an angioplasty procedure.

2. Application Area

Coronary Artery Disease (CAD): Balloon catheters are extensively used in angioplasty for the treatment of CAD, one of the most common cardiovascular diseases in North America.

Peripheral Artery Disease (PAD): The growing incidence of PAD, particularly in older adults, has increased the demand for balloon catheters to treat narrowed arteries in the limbs.

3. End User

Hospitals: Hospitals are the primary end-users of balloon catheters, as they have the necessary infrastructure and skilled personnel to perform angioplasty procedures.

Cardiac Catheterization Laboratories (Cath Labs): Cath labs within hospitals are dedicated to performing procedures involving balloon catheters.

Ambulatory Surgical Centers (ASCs): These centers are seeing an increase in demand for minimally invasive procedures, including those involving balloon catheters.

Regional Analysis

North America holds the largest share of the balloon catheters market, with the U.S. leading the region in terms of market size and growth. The U.S. market is primarily driven by the high prevalence of cardiovascular diseases, the availability of advanced healthcare infrastructure, and the strong presence of leading balloon catheter manufacturers. Canada is also witnessing growth in the market, albeit at a slower pace due to its smaller population and healthcare system.

Competitive Landscape

The North America balloon catheters market is highly competitive, with several key players vying for market share. These companies are focusing on expanding their product portfolios, improving product quality, and entering into strategic partnerships to strengthen their market position. Some of the leading players in the market include:

1. Medtronic PLC

Medtronic is one of the dominant players in the balloon catheters market, with a wide range of angioplasty balloon catheters. The company has a strong presence in North America, with a broad distribution network and a well-established customer base.

2. Boston Scientific Corporation

Boston Scientific is another major player in the North American balloon catheter market. The company offers a wide range of balloon catheters for coronary and peripheral interventions, including drug-eluting balloon catheters.

3. Abbott Laboratories

Abbott is known for its innovative medical devices, including balloon catheters for cardiovascular interventions. The company has made significant strides in developing drug-eluting balloons for improved clinical outcomes.

4. Cook Medical

Cook Medical is a global leader in medical device innovation, providing a comprehensive range of balloon catheters for coronary and peripheral applications.

5. Terumo Corporation

Terumo is a Japanese medical device company with a strong presence in the North American balloon catheter market. The company’s offerings include cutting-edge balloon catheters for various vascular procedures.

6. Johnson & Johnson (Ethicon)

Ethicon, a subsidiary of Johnson & Johnson, is a leading player in the global balloon catheter market, providing high-quality devices for both coronary and peripheral artery procedures.

FAQs

1. What is a balloon catheter?

A balloon catheter is a medical device used in angioplasty procedures to widen narrowed or blocked arteries. It consists of a thin, flexible tube with a balloon at the tip that is inflated to compress plaque or blood clots in the arteries.

2. What are the types of balloon catheters?

The main types of balloon catheters are angioplasty balloon catheters, cutting balloon catheters, scoring balloon catheters, and drug-eluting balloon catheters.

3. What are the key applications of balloon catheters?

Balloon catheters are primarily used in the treatment of coronary artery disease (CAD) and peripheral artery disease (PAD), as well as for other vascular interventions.

4. What factors are driving the growth of the North America balloon catheters market?

The major drivers include the increasing prevalence of cardiovascular diseases, technological advancements in balloon catheter design, a shift towards minimally invasive surgeries, and an ageing population.

5. Who are the leading players in the North America balloon catheters market?

Key players include Medtronic PLC, Boston Scientific Corporation, Abbott Laboratories, Cook Medical, Terumo Corporation, and Johnson & Johnson (Ethicon).

[soumyafwr]

Vascular Stent Market Size, Overview, Share and Forecast 2031